Mitochondrial bioenergetic remodeling underlies fingolimod-induced immunometabolic adaptation in multiple sclerosis.

González-Jiménez A, López-Cotarelo P, Moreno-Jerez A, Vela-Artiza J, Mena-Plaza E, Aladro Y, Pilo B, Oreja-Guevara C, Gómez-Estévez I, López-Pastor AR, et al.